Ticker symbol ORMP represents fractional public equity ownership in Oramed Pharmaceuticals Inc., listed on the NASDAQ stock exchange. Holding common shares provides investors with direct financial exposure to the clinical-stage biopharmaceutical sector, specifically capturing value creation or risk exposure tied to its oral insulin and metabolic disease drug pipeline development.